BlueWillow Biologics' Grant - II Round

BlueWillow Biologics raised a round of funding on March 06, 2017. Investors include National Institute of Allergy and Infectious Diseases.

BlueWillow Biologics is a privately-held biopharmaceutical company headquartered in Ann Arbor, Michigan, focused on developing and commercializing intranasal vaccines using its patented NanoVax┬« tech…

Articles about BlueWillow Biologics' Grant - II Round: